Skip to main content

Table 2 GP attitudes to antibiotic prescribing at baseline and follow-up by intervention group

From: Evaluation of a web-based intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial

  CRP group (n=73) Communication group (n=73) Combined group (n=83)
  Baseline (mean (SD)) Follow-up (mean (SD)) Effect size (Cohen’s d)a Baseline (mean (SD)) Follow-up (mean (SD)) Effect size (Cohen’s d) Baseline (mean (SD)) Follow-up (mean (SD)) Effect size (Cohen’s d)
Importance of reducing prescribing 6.03b (1.27) 6.22 (1.00) .15 5.85 (1.43) 6.34 (0.89) .35** 5.90 (1.08) 6.25 (1.05) .27*
Risks of reducing prescribing 4.37 (1.56) 4.88 (1.37) .31* 4.81 (1.61) 5.16 (1.45) .19 4.33 (1.47) 4.76 (1.50) .23*
Risk to relationship with patients 4.49 (1.62) 4.63 (1.58) .08 4.74 (1.80) 4.89 (1.61) .08 4.76 (1.41) 5.12 (1.33) .25*
Confidence to reduce prescribing 4.89 (1.49) 4.64 (1.49) -.13 4.71 (1.79) 5.12 (1.70) .21 4.86 (1.50) 5.28 (1.35) .25*
  1. *p < .05, **p < .01 for change in mean score (paired samples t-test).
  2. aEffect size (d) reported such that positive value represents positive change.
  3. bScores are on a scale from 1 (disagree strongly) to 7 (agree strongly).
Back to article page